5.2 a randomized, placebo-controlled study of lisdexamfetamine dimesylate in 4- to 5-year-old children with adhd

Ann Catherine Childress,Eric Lloyd,Leslie Jacobsen,Lhanoo Gunawardhana, Robert L. Findling

Journal of the American Academy of Child & Adolescent Psychiatry（2020）

引用 0|浏览0

暂无评分

摘要

In this poster, we aim to evaluate the acute efficacy, safety, and tolerability of lisdexamfetamine dimesylate (LDX) vs placebo (PBO) in children diagnosed with ADHD.

查看译文

关键词

lisdexamfetamine dimesylate,adhd,placebo-controlled,year-old

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要